You are using an outdated browser. Please upgrade your browser to improve your experience.

Tchem
SMAD3
Mothers against decapentaplegic homolog 3

Protein Summary
Description
Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD3/SMAD4 complex, activates transcription. Also can form a SMAD3/SMAD4/JUN/FOS complex at the AP-1/SMAD site to regulate TGF-beta-mediated transcription. Has an inhibitory effect on wound healing probably by modulating both growth and migration of primary keratinocytes and by altering the TGF-mediated chemotaxis of monocytes. This effect on wound healing appears to be hormone-sensitive. Regulator of chondrogenesis and osteogenesis and inhibits early healing of bone fractures. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator. The protein encoded by this gene belongs to the SMAD, a family of ...more
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000327367
  • ENSP00000332973
  • ENSG00000166949
  • ENST00000439724
  • ENSP00000401133
  • ENST00000537194
  • ENSP00000445348
  • ENST00000540846
  • ENSP00000437757

Symbol
  • MADH3
  • LDS3
  • LDS1C
  • MADH3
  • JV15-2
  • HSPC193
  • HsT17436
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
biological process
1
hub protein
1
molecular function
1
biological term
0.99
phosphatase
0.95


Protein Classes
IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 2340.96   (req: < 5)
Gene RIFs: 462   (req: <= 3)
Antibodies: 2043   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 2340.96   (req: >= 5)
Gene RIFs: 462   (req: > 3)
Antibodies: 2043   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 112
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligands: 4
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0